subscribeSubscribe
Eli Lilly`s Biologic Taltz (Ixekizumab) Receives Approval in the U.S.

Eli Lilly`s Biologic Taltz (Ixekizumab) Receives Approval in the U.S.
FDA
13 Sep 2023
Share Share
Eli Lilly forays into dermatological space with launch of psoriasis drug

Eli Lilly forays into dermatological space with launch of psoriasis drug
ECONOMIC TIMES
14 Mar 2023
Share Share
Lilly`s Taltz Now Available in New, Citrate-Free Formulation

Lilly`s Taltz Now Available in New, Citrate-Free Formulation
PRNEWSWIRE
08 Aug 2022
Share Share
Eli Lilly Taltz (Ixekizumab) Receives Supplemental Approval in the U.S.

Eli Lilly Taltz (Ixekizumab) Receives Supplemental Approval in the U.S.
FDA
04 May 2022
Share Share
NICE backs Lilly’s Taltz for axial spondyloarthritis

NICE backs Lilly’s Taltz for axial spondyloarthritis
PHARMATIMES
16 Jun 2021
Share Share
Taltz® Delivers More Cumulative Days with Completely Clear Skin for Adults

Taltz® Delivers More Cumulative Days with Completely Clear Skin for Adults
PRNEWSWIRE
23 Apr 2021
Share Share
Sanofi teams with virtual reality biotech on oral Dupixent successor

Sanofi teams with virtual reality biotech on oral Dupixent successor
Jason Mast ENDPTS
13 Apr 2021
Share Share
Cigna dangles $500 to patients who switch to Lilly`s Taltz

Cigna dangles $500 to patients who switch to Lilly`s Taltz
Arlene Weintraub FIERCEPHARMA
06 Apr 2021
Share Share
Taltz® (ixekizumab) Approved by Health Canada for the Treatment of Pediatric

Taltz® (ixekizumab) Approved by Health Canada for the Treatment of Pediatric
YAHOO
02 Apr 2021
Share Share
Ixekizumab May Restores Clinical Response in Patients Hidradenitis Suppurativa

Ixekizumab May Restores Clinical Response in Patients Hidradenitis Suppurativa
Denise Baez FIRSTWORLDPHARMA
05 Nov 2020
Share Share